Novel Agent Shows Promise in Early Parkinson’s Disease

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

The highly selective partial agonist at D1 and D5 receptors significantly improves motor function in patients recently diagnosed with Parkinson’s Disease
Medscape Medical News